Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Circular RNAs: Unlocking New Avenues in Liver Cancer
June 2025
Despite the well-documented association between HBV and HCC, the exact mechanisms driving HBV-induced HCC remain largely unknown.
Read more
29 May 2025
Pemafibrate Reduces Liver Fat and Heart Disease Risk
A study has revealed that pemafibrate is more effective than omega-3 fatty acid ethyl in reducing fatty liver index.
27 May 2025
Dual Diabetes Drug Regimen Shows Promise for MASLD
Discover a study that suggests that dual therapy could offer a safer and more effective approach to treating MASLD.
25 May 2025
Bariatric Surgery Alters Fibrinogen Profiles in MASLD
A recent study investigated how different naturally occurring fibrinogen variants relate to obesity, MASLD, and liver fibrosis severity.
23 May 2025
AI Model Enhances Liver Cancer Risk Prediction Accuracy
PLAN-B-DF was trained and internally validated on a large cohort of 5,585 patients, and externally validated.
21 May 2025
Causes of Death in Metabolic Dysfunction-Associated Liver Disease
A recent nationwide Swedish cohort study involving over 13,000 patients with MASLD compared mortality rates and causes of death.
19 May 2025
Rising Impact of MASLD on Pregnancy Outcomes
Breastfeeding, known for its metabolic benefits to both parent and infant, is encouraged in those with MASLD.
17 May 2025
Faecal Calprotectin as a Biomarker for Sepsis Liver Dysfunction
Discover a study that explored the use of faecal calprotectin as a biomarker for sepsis in liver dysfunction. Learn more.
15 May 2025
Steatotic Liver Disease and Frailty in Older Adults
A recent study offers new insight into the prevalence and implications of steatotic liver disease in older adults.
Loading posts...
« Previous
1
2
3
4
5
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View